Positive expression of KIF20A correlates with a poor prognosis and tumour growth and progression in early-stage of several types of cancer including breast (78), colorectal (79) and cervical cancers (65) but also PDAC (67) and glioma (80). This evidence concerns the gene KIF20A and cervical carcinoma.